KMT2A, known as myeloid/lymphoid or mixed-lineage leukemia (MLL), is a well-recognized leukemia-related gene and is rearranged in approximately 75% of infants with B-ALL, particularly in those less than 6 months of age [26]. Here, KMT2A is linked to leukemia.